RT @AAPSComms: #AAPSPT study on ritonavir: In vivo pharmacokinetic comparison bw two dosage forms resulted in equiv exposure w/ approx 20…
156 followers
396 followers
RT @AAPSComms: #AAPSPT study on ritonavir: In vivo pharmacokinetic comparison bw two dosage forms resulted in equiv exposure w/ approx 20…
226 followers
RT @AAPSComms: #AAPSPT study on ritonavir: In vivo pharmacokinetic comparison bw two dosage forms resulted in equiv exposure w/ approx 20…
4,924 followers
#AAPSPT study on ritonavir: In vivo pharmacokinetic comparison bw two dosage forms resulted in equiv exposure w/ approx 20% Cmax redux for the KinetiSol tablet. These performance gains were realized w/ a concurrent redux in dosage form mass of 45%. https